The wait is over—it’s John Puskas! 🎧
Surgeon, researcher, inventor, and educator John Puskas joins @TCTMD_Yael in the latest episode of TCTMD’s Hearts & Minds podcast for a conversation about knowledge sharing, new ways of thinking, and advances in surgical coronary revascularization. Plus, did you know he’s a pilot?
Listen to the full episode: bit.ly/486dOkS
#CardiacSurgery
Heart failure care has advanced, but the US burden continues to grow. A new report shows mortality is rising as more Americans are being affected, with obesity, diabetes, and other comorbidities potentially contributing to the trend. #HeartFailure #PublicHealth bit.ly/4rZGy8a
Let's play a little game. A new episode of @TCTMD's Hearts & Minds podcast is dropping tomorrow. Who do you think sat down with host @TCTMD_Yael for this month's conversation?
What’s on the horizon at TCT 2026? From 28 late-breaking studies to hands-on training and AI’s expanding role in cardiology, @TCTMD_Caitlin previews the science and sessions to watch in San Diego. bit.ly/4sfyWhV
For patients with prior CABG but no MI, the cardiovascular benefits of evolocumab hold up in a VESALIUS-CV analysis. The findings should encourage surgeons to take a more active role in lipid management after patients leave the OR. bit.ly/4s76uip
Intraoperative Hypotension Tied to Worse Outcomes After Stroke Thrombectomy bit.ly/47opdfP
For rural patients with AAA who undergo EVAR, new US registry data show that care gaps exist for screening, treatment, and follow-up. Researchers say a community-level approach to change may help. bit.ly/4zqOZvA
TCTMD retweeted
One meeting. Endless possibilities. ✨
This is your ultimate #TCT2026 checklist. The only question is: How many will you check off? ✅🌴 ow.ly/qqFn50ZYy8z
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost @padideh_daneii
Even among operators new to the procedure, deep-vein arterialization in "no-option" CLTI patients improved pain, with amputation-free survival of 76.3% at 1 year in PROMISE III.bit.ly/4esxVxf
Science, networking, and beyond: With #TCT2026 approaching, Fellow Talk blogger @Shikha_Cardio shares seven things you can look forward to at this year’s meeting. #FellowsForum bit.ly/4igrSy7
As Years Pass, Mortality Grows Higher With TAVI vs SAVR in Low-risk Patients: Meta-analysis bit.ly/3U8uSUb
SGLT2 Inhibition Promising in ANOCA Patients With Microvascular Dysfunction bit.ly/4ySBapY
Two novel incretin-based agents appear highly effective in type 2 diabetes, with the TRIUMPH-2 and SYNCHRONIZE-2 studies of #retatrutide and #survodutide, respectively, showing reductions in body weight and better glycemic control. bit.ly/4yQK8Ef
Heading to AHA in Chicago? @Drroxmehran and Joanna Chikwe preview the research, discussions, and in-person connections to expect at the meeting. Listen to the full #RoxHeartRadio podcast for an inside look at what’s ahead, then follow TCTMD’s #AHA coverage for the latest updates from Chicago. bit.ly/47V8wbR